off label use of semaglutide 🩺 𝗠𝗲𝗱𝗶 𝗡𝗲𝘄𝘀 𝗨𝗽𝗱𝗮𝘁𝗲 𝗪𝗵𝗮𝘁 𝗱𝗿𝗶𝘃𝗲𝘀 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘁𝗼 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗲 𝗼𝗿 𝘀𝘁𝗼𝗽 𝗼𝗳𝗳-𝗹𝗮𝗯𝗲𝗹 𝘀𝗲𝗺𝗮𝗴𝗹𝘂𝘁𝗶𝗱𝗲 𝗳𝗼𝗿 𝘄𝗲𝗶𝗴𝗵𝘁 𝗹𝗼𝘀𝘀? 𝗔 𝗻𝗲𝘄 𝘀𝘁𝘂𝗱𝘆 𝗿𝗲𝘃𝗲𝗮𝗹𝘀 𝘁𝗵𝗮𝘁 𝗽𝗲𝗿𝗰𝗲𝗶𝘃𝗲𝗱 Semaglutide for Weight Loss: A

Trial REIMAGINE 2 Phase 3 Duration Reported 2026 Population (N) Adults with T2D Key Result Sponsor reported HbA1c reduction of 1.91 percentage points and 14.2% weight loss

FDA-approved label for semaglutide injection

The 99%+ purity standard maintained by PSPeptides ensures that research outcomes reflect the genuine pharmacology of retatrutide rather than impurity-related artifacts

Wegovy 7.2mg: 20.7% average weight loss at 72 weeks (STEP UP, Lancet 2025)

13 June 2023

People feel like drugs cost too much, and they don't understand how much they're going to cost, and they're upset because they can't get drugs that they want